Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | 16.96%-8.91M | 35.42%-2.01M | 20.32%-2.16M | 6.66%-2.52M | -0.54%-2.23M | -2.76%-10.73M | -39.92%-3.11M | 11.89%-2.71M | 3.98%-2.7M | 5.14%-2.21M |
| Net profit before non-cash adjustment | -0.10%-10.47M | -30.62%-2.5M | 16.47%-2.53M | 3.00%-2.68M | -0.18%-2.75M | 23.17%-10.46M | 31.35%-1.92M | -2.54%-3.03M | 12.97%-2.76M | 41.41%-2.75M |
| Total adjustment of non-cash items | -1.18%1.59M | 37.65%351K | -8.82%465K | -15.01%385K | -0.51%390K | -52.69%1.61M | -15.84%255K | 60.38%510K | 24.11%453K | -83.78%392K |
| -Depreciation and amortization | -7.17%3.78M | -15.76%882K | 0.00%1.01M | -7.82%955K | -4.67%939K | 6.09%4.08M | 5.94%1.05M | 6.67%1.01M | 11.16%1.04M | 0.82%985K |
| -Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | ---- | ---- | 240.95%44.5K | ---- | ---- | ---- | ---- |
| -Disposal profit | --0 | ---- | ---- | ---- | ---- | -119.77%-358K | ---- | ---- | ---- | ---- |
| -Other non-cash items | -4.03%-2.19M | -22.35%-531K | -9.05%-542K | 2.23%-570K | 7.42%-549K | 4.98%-2.11M | 82.39%-434K | 20.61%-497K | -2.82%-583K | -141.18%-593K |
| Changes in working capital | 97.93%-39K | 110.10%146K | 50.52%-95K | 42.31%-225K | -3.57%135K | -690.05%-1.89M | -639.49%-1.45M | 56.46%-192K | -19,400.00%-390K | 318.75%140K |
| -Change in receivables | 209.47%370K | 42.90%-205K | 498.78%327K | 96.77%-1K | 85.82%249K | -61.07%-338K | -1,121.31%-359K | 70.29%-82K | -133.33%-31K | 316.13%134K |
| -Change in inventory | -52.42%128K | -66.67%19K | 514.29%87K | -112.20%-5K | -85.94%27K | 1,213.83%269K | 136.98%57K | -110.77%-21K | -47.44%41K | 234.27%192K |
| -Change in payables | 70.48%-537K | 129.02%332K | -471.91%-509K | 45.25%-219K | 24.19%-141K | -36,492.23%-1.82M | -395.59%-1.14M | 75.28%-89K | -131.21%-400K | -231.91%-186K |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | 7.69%-12K | 0.00%-3K | 0.00%-3K | 25.00%-3K | 0.00%-3K | -13K | -3K | 0.00%-3K | -100.00%-4K | 0.00%-3K |
| Interest received (cash flow from operating activities) | 3.96%2.2M | 22.20%534K | 9.00%545K | -2.39%573K | -7.38%552K | -4.42%2.12M | -30.53%437K | -20.51%500K | 3.16%587K | 52.43%596K |
| Tax refund paid | 3K | 0 | 0 | 0 | 3K | 0 | 0 | 0 | 0 | 0 |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | 22.12%-6.72M | 44.80%-1.48M | 26.92%-1.62M | 7.88%-1.95M | -3.27%-1.67M | -4.85%-8.63M | -68.75%-2.67M | 9.67%-2.21M | 5.70%-2.12M | 16.70%-1.62M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | -90.19%-5.25M | 105.49%100K | ---1.11M | -6,356.76%-2.39M | -105.41%-1.86M | -13.82%-2.76M | -88.66%-1.82M | --0 | 92.46%-37K | -102.91%-905K |
| Net investment product transactions | 20.80%12.91M | -40.13%1.56M | -4.47%3.1M | 268.67%4.72M | -0.65%3.54M | -64.34%10.69M | -84.38%2.61M | 30.03%3.24M | -83.96%1.28M | 27.03%3.56M |
| Investing cash flow | -3.37%7.66M | 110.65%1.66M | -38.54%1.99M | 87.45%2.33M | -36.83%1.68M | -71.23%7.93M | -96.31%789K | 228.38%3.24M | -80.35%1.24M | 12.65%2.65M |
| Financing cash flow | ||||||||||
| Increase or decrease of lease financing | -100.00%-28K | -600.00%-7K | ---7K | 25.00%-6K | -60.00%-8K | 10.74%-14K | 78.66%-1K | --0 | 0.00%-8K | -150.00%-5K |
| Cash dividends for minorities | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Interest paid (cash flow from financing activities) | ---- | ---- | ---- | ---- | ---- | -17.24%-12.92K | ---- | ---- | ---- | ---- |
| Financing cash flow | -100.00%-28K | -600.00%-7K | ---7K | 25.00%-6K | -60.00%-8K | 99.75%-14K | 99.98%-1K | --0 | 0.00%-8K | -150.00%-5K |
| Net cash flow | ||||||||||
| Beginning cash position | -50.00%251K | 8.58%721K | -19.50%578K | -87.79%190K | -50.00%251K | -99.34%502K | 33.87%664K | -86.79%718K | 24.38%1.56M | 83.88%502K |
| Current changes in cash | 228.19%914K | 109.49%179K | -64.24%368K | 142.24%373K | -100.58%-6K | -105.23%-713K | -113.34%-1.89M | 120.67%1.03M | -121.69%-883K | 152.33%1.03M |
| Effect of exchange rate changes | -173.59%-340K | -105.09%-75K | 79.22%-225K | -66.67%15K | -303.70%-55K | 279.98%462K | 250.35%1.47M | -3,027.03%-1.08M | -60.87%45K | -95.27%27K |
| End cash Position | 228.69%825K | 228.69%825K | 8.58%721K | -19.50%578K | -87.79%190K | -99.72%251K | -99.72%251K | 33.87%664K | -86.79%718K | 24.38%1.56M |
| Free cash flow | -1.64%-11.97M | 71.83%-1.38M | -22.99%-2.72M | -101.39%-4.34M | -39.87%-3.53M | -10.38%-11.78M | -90.31%-4.88M | 25.60%-2.21M | 21.26%-2.16M | -5.60%-2.53M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.